Mayne Pharma Group Ltd (MYX) — Cash Flow Quality Index
Mayne Pharma Group Ltd (MYX) has a Cash Flow Quality Index of -0.20x as of September 2022. Operating cash flow of AU$-28.40 Million is below net income of AU$145.01 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Mayne Pharma Group Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Mayne Pharma Group Ltd Cash Flow Quality Index (2010–2023)
Historical Cash Flow Quality Index for Mayne Pharma Group Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see MYX cash generation efficiency.
Annual Cash Flow Quality Index for Mayne Pharma Group Ltd (2010–2023)
Year-by-year earnings quality comparison for Mayne Pharma Group Ltd.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.36x | AU$-42.71 Million | AU$117.25 Million | ▼ -111.7% |
| 2017 | -0.17x | AU$-15.24 Million | AU$88.57 Million | ▼ -112.0% |
| 2016 | 1.43x | AU$53.50 Million | AU$37.35 Million | ▼ -50.4% |
| 2015 | 2.89x | AU$22.42 Million | AU$7.76 Million | ▲ +135.4% |
| 2014 | 1.23x | AU$26.14 Million | AU$21.29 Million | ▼ -43.6% |
| 2012 | 2.18x | AU$13.39 Million | AU$6.15 Million | ▼ -10.6% |
| 2011 | 2.43x | AU$4.09 Million | AU$1.68 Million | ▼ -22.8% |
| 2010 | 3.15x | AU$10.26 Million | AU$3.25 Million | — |